52 filings
8-K
FEMY
Femasys Inc
9 May 24
Results of Operations and Financial Condition
8:35am
8-K
FEMY
Femasys Inc
24 Apr 24
Regulation FD Disclosure
9:11am
8-K
FEMY
Femasys Inc
28 Mar 24
Results of Operations and Financial Condition
4:23pm
8-K
FEMY
Femasys Inc
20 Mar 24
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
8:18am
8-K
FEMY
Femasys Inc
6 Mar 24
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
9:09am
8-K
cugl37
28 Feb 24
Disrupting Convention in Women’s Health Through Continuous Innovation February 2024 Corporate Presentation 1
9:16am
8-K
ltwg cwnkgaah3i06
6 Feb 24
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
8:47am
8-K
p0mxv
29 Nov 23
Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch
4:05pm
8-K
p8kx 9l4sry
21 Nov 23
Departure of Directors or Certain Officers
5:30pm
8-K
3em0xlkpnywkpmw9c
15 Nov 23
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
5:19pm
8-K
71flxxctlwqgo5i0ky9x
14 Nov 23
Femasys Inc. Announces Financial Results for the Third Quarter Ended
12:00am
8-K
ciwdzkxwui
11 Oct 23
Other Events
8:01am
8-K
ugwcnd5g
3 Oct 23
Other Events
9:28am
8-K
3y8 x5kw23yu
27 Sep 23
Disrupting Convention in Women’s Health Through Continuous Innovation September 2023 Corporate Presentation 1
8:19am
8-K
fts9a6sfuoe53q6 sm
6 Sep 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
cuqzehwi9dwpk h1
10 Aug 23
Femasys Inc. Announces Financial Results for the Second Quarter Ended Second Quarter 2023 Financial Results
8:05am
8-K
y4y1q9w5ms 3z7zuoi
3 Aug 23
Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc
9:04am
8-K
tbrbsgit21obs 2eo5fh
27 Jul 23
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control
9:04am
8-K
6tdl uus715w25twpc6
26 Jun 23
Disrupting Convention in Women’s Health Through Continuous Innovation June 2023 Corporate Presentation 1
8:05am
8-K
8bhe8h
21 Jun 23
Submission of Matters to a Vote of Security Holders
5:18pm